Cannabis Science Conference West Returns for Successful Fourth Year


Rachelle Gordon

September 11th, 2019

News


The cannabis industry may still be in its infancy, but several key conferences and events have already cemented their places in the “must attend” category for professionals in the space. One such show is the Cannabis Science Conference (CSC), which recently held its 4th annual west coast edition at the Oregon Convention Center in Portland. A meeting of the top minds from across the marijuana marketplace, the CSC is well-known for attracting celebrities, medical professionals, scientists, thought leaders, and executives alike. 

 

“Our 2019 Cannabis Science Conference West was a huge success!” exclaimed CSC Founder, President, and CEO Josh Crossney. “We’re extremely grateful for the support we receive year after year from our speakers, attendees, sponsors, exhibitors and media partners. Without them, none of this would be possible.”

“Amazon” John Easterling and Olivia-Newton John deliver the plenary address at Cannabis Science Conference East 2019 (photo credit @cannakopiaorg)

This year’s event attracted thousands of attendees representing 17 countries seeking out the latest cutting-edge cannabis research and news from the experts themselves. 

 

Attendees were especially moved by Olivia Newton-John and Amazon John Easterling’s plenary address on Thursday entitled “Plant Medicine: A Personal Healing Journey”. 

 

“Cannabis weaned me off Morphine,” Newton-John told the crowd. The singer and actress has been an outspoken proponent of medical marijuana and botanical treatments after utilizing it in her battle against cancer.

 

“It has been an honor getting to know Olivia, John and their family over the past few years,” Crossney adds. “They really are two of the most caring, loving people I’ve ever met. I’m forever grateful for their friendship and for supporting the show.”

 

Another highlight session was the “Professional Athletes for Cannabis” panel that featured Marvin Washington (NFL), Cliff Robinson (NBA), Riley Cote (NHL), and Anna Symonds (WPL Rugby), with Dr. Sue Sisley acting as moderator. This panel covered the importance of cannabis being an option in professional sports as opposed to dangerous opiates and other pharmaceuticals. Attendees also heard from other industry leading keynote speakers like Dr. Ethan Russo, Dr. Dustin Sulak, Dr. Markus Roggen and Jeff Lowenfels, just to name a few.

 

“This is not the typical cannabis conference/trade show I’m accustomed to as it was loaded with PhD’s, scientists, researchers and professional wellness advocates that are sharing information to continue this cannabis freedom movement,” exclaimed speaker Brian Rice, Director of Research and Development at Boveda, makers of two-way humidity control technology. “Everything and everyone there seemed 100% focused on scientific topics – genetics, the endocannabinoid system, and human safety to name a few.”

 

Next, it’s all eyes on Maryland as Cannabis Science Conference East returns April 6th – 8th at the Baltimore Convention Center. This flagship show promises to be bigger and better than ever as the nation prepares for broader legalization, more clinical research, and a bevy of investment dollars that continues to flow. Reserve your tickets here – CFN Media will bring you more coverage on this top event so stay tuned!

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Rachelle Gordon

Rachelle Gordon is a Minneapolis-based writer. Find her online at www.rachellegordon.net.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading